March 12, 2014 | Israeli pharmaceutical company Can-Fite Biopharma has raised $5 million in private placement from US investors. The company says it will use the proceeds for further clinical trials of its psoriasis, glaucoma, and liver cancer treatments.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments